Evidence map›Paper›PMID 23430612›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions.

Janine M van Gils, Bhama Ramkhelawon, Luciana Fernandes, Merran C Stewart, Liang Guo, Tara Seibert, Gustavo B Menezes, Denise C Cara, Camille Chow, T Bernard Kinane and 5 more

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Axon guidance molecules in immunometabolic diseases.Inflammation and regeneration · 2022
    Review
  18. Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Fetal Blood Flow and Genetic Mutations in Conotruncal Congenital Heart Disease.Journal of cardiovascular development and disease · 2021
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Janine M van GilsMarc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, NewYork University School of Medicine, New York, NY 10016, USA.
Bhama Ramkhelawon
Luciana Fernandes
Merran C Stewart
Liang Guo
Tara Seibert
Gustavo B Menezes
Denise C Cara
Camille Chow
T Bernard Kinane
Edward A Fisher
Mercedes Balcells
Jacqueline Alvarez-Leite
Adam Lacy-Hulbert
Kathryn J Moore
Harvard University · USMassachusetts General Hospital · USMassachusetts Institute of Technology · USUniversity of Ottawa · CAUniversidade Federal de Minas Gerais · BR

Funding

Molecular Regulation of Atherosclerosis Regression - RenewalR01HL084312 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A · 2006 to 2024
$11.4M
Vascular Drug Delivery - Supplement for EquipmentR01GM049039 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI EDELMAN, ELAZER R · 1994 to 2019
$8.9M
Immunomodulatory functions of neuronal guidance cuesRC1HL100815 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOORE, KATHRYN J · 2009 to 2010
$997k
CIHRNHLBI NIH HHS R01 HL084312NHLBI NIH HHS RC1 HL100815NHLBI NIH HHS RC1HL100815NIGMS NIH HHS R01 GM049039
6 · The paper itself

Abstract

objectiveEmerging evidence suggests that neuronal guidance cues, typically expressed during development, are involved in both physiological and pathological immune responses. We hypothesized that endothelial expression of such guidance cues may regulate leukocyte trafficking into the vascular wall during atherogenesis. APPROACH AND

resultsWe demonstrate that members of the netrin, semaphorin, and ephrin family of guidance molecules are differentially regulated under conditions that promote or protect from atherosclerosis. Netrin-1 and semaphorin3A are expressed by coronary artery endothelial cells and potently inhibit chemokine-directed migration of human monocytes. Endothelial expression of these negative guidance cues is downregulated by proatherogenic factors, including oscillatory shear stress and proinflammatory cytokines associated with monocyte entry into the vessel wall. Furthermore, we show using intravital microscopy that inhibition of netrin-1 or semaphorin3A using blocking peptides increases leukocyte adhesion to the endothelium. Unlike netrin-1 and semaphorin3A, the guidance cue ephrinB2 is upregulated under proatherosclerotic flow conditions and functions as a chemoattractant, increasing leukocyte migration in the absence of additional chemokines.

conclusionsThe concurrent regulation of negative and positive guidance cues may facilitate leukocyte infiltration of the endothelium through a balance between chemoattraction and chemorepulsion. These data indicate a previously unappreciated role for axonal guidance cues in maintaining the endothelial barrier and regulating leukocyte trafficking during atherogenesis.

Indexed as

Gene Expression RegulationHomeostasisAnimalsAtherosclerosisCell AdhesionCell MovementCells, CulturedEndothelium, VascularEphrin-B2HumansLeukocytesMiceMice, Inbred C57BLNerve Growth FactorsNetrin-1Semaphorin-3AEphrin-B2Nerve Growth FactorsNetrin-1NTN1 protein, humanNtn1 protein, mouseSema3a protein, mouseSemaphorin-3ATumor Suppressor Proteins

Identifiers

PMID23430612
PMCPMC3647028
OpenAlexW2166765907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.